{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:28:43Z","timestamp":1776187723693,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> Pompe disease is a rare genetic disease produced by mutations in the GAA gene leading to progressive skeletal and respiratory muscle weakness. T1-weighted magnetic resonance imaging is useful to identify fatty replacement in skeletal muscles of late-onset Pompe disease (LOPD) patients. Previous studies have shown that replacement by fat correlates with worse results of muscle function tests. Our aim was to investigate if fat replacement of muscles involved in the ventilation process correlated with results of the spirometry and predicted respiratory muscle impairment in LOPD patients over time.<\/jats:p><jats:p><jats:bold>Materials and Methods:<\/jats:bold> We studied a cohort of 36 LOPD patients followed up annually in our center for a period of 4 years. We quantified muscle fat replacement using Mercuri score of the thoracic paraspinal and abdominal muscles and the pillars of the diaphragm. We correlated the combined Mercuri scores of these areas with spirometry results and the need of respiratory support.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> We found a statistically significant correlation (Spearman test, <jats:italic>p<\/jats:italic> &amp;lt; 0.05; coefficient of correlation &amp;gt; 0.6) between forced vital capacity seated and lying and fat fraction score of all muscle groups studied. The group of patients who needed respiratory support had higher fat fraction scores than patients not requiring ventilatory support. Higher fat replacement in these areas correlated with worse progression in spirometry values over time.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Fat replacement of paraspinal, abdominal, and trunk muscles correlates with results of spirometry and is able to predict worsening in respiratory muscle function tests that could lead to an emerging ventilatory dysfunction. Therefore, the identification of fat replacement in these muscle groups should lead to a closer monitorization of patients. Radiologic evaluation of diaphragm pillars in T1-weighted imaging axial sequences could also be helpful to predict respiratory insufficiency.<\/jats:p>","DOI":"10.3389\/fneur.2021.621257","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T05:25:09Z","timestamp":1614576309000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Correlation Between Respiratory Accessory Muscles and Diaphragm Pillars MRI and Pulmonary Function Test in Late-Onset Pompe Disease Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"David","family":"Reyes-Leiva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Alonso-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Mayos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Nu\u00f1ez-Peralta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Llauger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izaskun","family":"Belmonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Pedrosa-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"D\u00edaz-Manera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe disease: from basic science to therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1212\/WNL.0b013e31818da91e","article-title":"Diagnosis of glycogenosis type II","volume":"71","author":"Bembi","year":"2008","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1212\/WNL.0000000000004711","article-title":"Long-term benefit of enzyme replacement therapy in Pompe disease","volume":"89","author":"Kuperus","year":"2017","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s10545-018-0166-3","article-title":"Long-term follow-up of 17 patients with childhood Pompe disease treated with enzyme replacement therapy","volume":"41","author":"van der Meijden","year":"2018","journal-title":"J Inherit Metab Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1756","DOI":"10.1212\/WNL.0000000000008441","article-title":"Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease","volume":"93","author":"Harlaar","year":"2019","journal-title":"Neurology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","article-title":"Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis","volume":"264","author":"Schoser","year":"2016","journal-title":"J Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.24908","article-title":"The neurology of acutely failing respiratory mechanics","volume":"81","author":"Wijdicks","year":"2017","journal-title":"Ann Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.nmd.2017.11.010","article-title":"Imaging of respiratory muscles in neuromuscular disease: a review","volume":"28","author":"Harlaar","year":"2018","journal-title":"Neuromuscul Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMra1007236","article-title":"Dysfunction of the diaphragm","volume":"366","author":"McCool","year":"2012","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nmd.2003.08.003","article-title":"Muscle MRI in adult-onset acid maltase deficiency","volume":"14","author":"Pichiecchio","year":"2004","journal-title":"Neuromuscul Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.nmd.2011.06.748","article-title":"Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: involvement patterns","volume":"21","author":"Carlier","year":"2011","journal-title":"Neuromuscul Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0163493","DOI":"10.1371\/journal.pone.0163493","article-title":"Muscle MRI findings in childhood\/adult onset pompe disease correlate with muscle function","volume":"11","author":"Figueroa-Bonaparte","year":"2016","journal-title":"PLoS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/ene.13285","article-title":"European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience","volume":"24","author":"van der Ploeg","year":"2017","journal-title":"Eur J Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/01.wnl.0000324927.28817.9b","article-title":"Distinct muscle imaging patterns in myofibrillar myopathies","volume":"71","author":"Fischer","year":"2008","journal-title":"Neurology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/jcsm.12555","article-title":"Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles","volume":"11","author":"Nu\u00f1ez-Peralta","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/jnnp-2018-319578","article-title":"Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy","volume":"90","author":"Alonso-Jimenez","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/jnnp-2017-317488","article-title":"Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials","volume":"89","author":"Diaz-Manera","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1212\/WNL.0000000000002772","article-title":"Teaching video neuroimages: the Beevor sign in late-onset Pompe disease","volume":"86","author":"Garibaldi","year":"2016","journal-title":"Neurology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","article-title":"Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review","volume":"260","author":"Toscano","year":"2012","journal-title":"J Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ymgme.2013.06.023","article-title":"Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function","volume":"110","author":"Gaeta","year":"2013","journal-title":"Mol Genet Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12890-015-0058-3","article-title":"Lung MRI and impairment of diaphragmatic function in Pompe disease","volume":"15","author":"Wens","year":"2015","journal-title":"BMC Pulm Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.nmd.2015.09.003","article-title":"Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: new insights from a comparative study by MRI and respiratory function assessment","volume":"25","author":"Gaeta","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s10072-020-04316-6","article-title":"Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease","volume":"41","author":"Ruggeri","year":"2020","journal-title":"Neurol Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/WCO.0000000000000851","article-title":"The increasing role of muscle MRI to monitor changes over time in untreated and treated muscle diseases","volume":"33","author":"Nu\u00f1ez-Peralta","year":"2020","journal-title":"Curr Opin Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ana.25804","article-title":"MRI in neuromuscular diseases: an emerging diagnostic tool and biomarker for prognosis and efficacy","volume":"88","author":"Dahlqvist","year":"2020","journal-title":"Ann Neurol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27099","article-title":"Skeletal muscle magnetic resonance imaging in Pompe disease","author":"D\u00edaz-Manera","year":"2020","journal-title":"Muscle Nerve"},{"key":"B30","doi-asserted-by":"publisher","first-page":"10898","DOI":"10.1038\/s41598-018-29170-7","article-title":"Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study","volume":"8","author":"Figueroa-Bonaparte","year":"2018","journal-title":"Sci Rep."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.621257\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T05:25:12Z","timestamp":1614576312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.621257\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":30,"alternative-id":["10.3389\/fneur.2021.621257"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.621257","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"article-number":"621257"}}